Cancer Genetics Announces Strong First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Cancer Genetics (CGIX) Tops Q1 EPS by 10c
May 12, 2015 7:32 AM EDTCancer Genetics (NASDAQ: CGIX) reported Q1 EPS of ($0.44), $0.10 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $3.91 million.
For earnings history and earnings-related data on Cancer Genetics (CGIX) click here.
... More